-+ 0.00%
-+ 0.00%
-+ 0.00%

ARCTURUS THERAPEUTICS RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR THE STARR® MRNA VACCINE CANDIDATE ARCT-2304 FOR PANDEMIC INFLUENZA A VIRUS H5N1

Reuters·04/10/2025 12:00:29

Please log in to view news